Our mission is to triple the pancreatic cancer survival rate by 2030 and dramatically improve the quality of life for those impacted by the disease.

PanKind, The Australian Pancreatic Cancer Foundation, is exclusively dedicated to improving outcomes for Australians impacted by pancreatic cancer.

We are achieving results through a strategic investment in groundbreaking medical research and critically, PanKind is often the first to provide funding for these projects. We are the lead funder, identifying the potential for patients and providing the initial investment to enable projects to grow bigger and have a greater impact.

Early-stage pancreatic cancer rarely causes signs or symptoms, which can make it difficult to diagnose, that is why we are working towards a breakthrough in early detection. We also support patients and carers through information and resources, and advocating for better patient outcomes.

We invite you to join us on the journey to improve survival rates and the quality of life for the thousands of Australians affected by this disease every year.

Take Action Our Approach

We are investing in Australia's top pancreatic cancer research talent.

Achievements

flask-icon
Invested over $14 million into pancreatic cancer research
write-icon
Lead funder of strategic, Early Detection research projects
walk-icon
United over 30,000 Australians at our national walks
ribbon-icon
Driving the agenda and raising awareness of the disease nationwide

Latest news

PBAC reviews new treatment

Dec 21 2023

Your opinion is required to help the Pharmaceutical Benefits Advisory Committee (PBAC) evaluate whether a new treatment should be funded for metastatic pancreatic cancer.

Read story ➞
All news